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MDA5, a viral double-stranded RNA (dsRNA) re-
ceptor, shares sequence similarity and signaling
pathways with RIG-I yet plays essential functions in
antiviral immunity through distinct specificity for viral
RNA. Revealing themolecular basis for the functional
divergence, we report here the crystal structure
of MDA5 bound to dsRNA, which shows how, using
the same domain architecture, MDA5 recognizes
the internal duplex structure, whereas RIG-I recog-
nizes the terminus of dsRNA. We further show that
MDA5 uses direct protein-protein contacts to stack
along dsRNA in a head-to-tail arrangement, and
that the signaling domain (tandem CARD), which
decorates the outside of the core MDA5 filament,
also has an intrinsic propensity to oligomerize into
an elongated structure that activates the signaling
adaptor, MAVS. These data support amodel in which
MDA5 uses long dsRNA as a signaling platform to
cooperatively assemble the core filament, which in
turn promotes stochastic assembly of the tandem
CARD oligomers for signaling.
INTRODUCTION
MDA5 and RIG-I are cytoplasmic viral RNA receptors in the
vertebrate innate immune system. They share high sequence
similarity and a common signaling adaptor, MAVS, that activates
interferon (IFN) signaling pathways. Despite these similarities,
they play nonredundant functions in antiviral immunity by recog-
nizing largely distinct groups of viruses and viral RNAs. MDA5
detects long-duplex RNAs in the genome of double-stranded
RNA (dsRNA) viruses or dsRNA replication intermediates of
positive-strand viruses, such as Encephalomyocarditis virus276 Cell 152, 276–289, January 17, 2013 ª2013 Elsevier Inc.(EMCV) and vesicular stomatitis virus (VSV) (Kato et al., 2011;
Triantafilou et al., 2012). By contrast, RIG-I detects the 50 triphos-
phate group (50ppp) and blunt end of short dsRNAs or single-
stranded RNA (ssRNA) hairpins often present in a wide range
of negative strand viruses, such as influenza A, and some
positive- and double-stranded RNA viruses (Baum et al., 2010;
Schlee et al., 2009).
MDA5 and RIG-I consist of the N-terminal tandem caspase
activation recruitment domains (2CARD) that activate MAVS,
the central helicase domain responsible for RNA-dependent
ATP hydrolysis, and the C-terminal domain (CTD). Recent crystal
structures of RIG-I provided a detailed view of how RIG-I recog-
nizes the dsRNA end and how 2CARD-mediated signaling
activity is autoregulated in the absence of viral dsRNA (Jiang
et al., 2011; Kowalinski et al., 2011; Luo et al., 2011). These struc-
tures, and those of the isolated CTD (Lu et al., 2010; Wang et al.,
2010), showed that the RIG-I CTD plays a predominant role in
high-affinity binding and selectivity for dsRNA containing the
50ppp and blunt end (Cui et al., 2008; Takahasi et al., 2008). In
contrast to RIG-I, the MDA5 CTD displays dsRNA affinity that
is orders of magnitude lower than that of full-length MDA5
(Peisley et al., 2011), suggesting different molecularmechanisms
for dsRNA recognition by MDA5 and RIG-I.
How MDA5 utilizes a domain architecture similar to that of
RIG-I to effect vastly different RNA selectivity has remained
unclear, largely due to the lack of the MDA5:dsRNA complex
structure. Previously, we have shown that MDA5 cooperatively
assembles into filamentous oligomers along dsRNA, which is
important for high-affinity interaction with long dsRNA (Peisley
et al., 2011), and that filament formation correlates with the
length-dependent signaling activity in cells due to filament
end-disassembly triggered by ATP hydrolysis (Peisley et al.,
2012). This is distinct from RIG-I, which tightly binds to dsRNA
as a monomer and shows little or no cooperativity in dsRNA
binding (Peisley et al., 2011). A previous atomic force micros-
copy study proposed that RIG-I also forms filaments (Binder
et al., 2011), but we have not observed such filaments by
electron microscopy (EM) under the same conditions used
for MDA5.
Detailed studies of the MDA5 filament architecture have been
challenging partly due to the difficulty of crystallizing filamentous
proteins and the potential flexibility of 2CARD upon dsRNA
binding. In particular, the latter has been a challenge in RIG-I
as well as MDA5 as evidenced by the lack of crystal structures
of full-length RIG-I bound to dsRNA. Here, we used three
approaches to dissect the architecture of the full-length MDA5
filament and dsRNA recognition mechanism. First, we deter-
mined the crystal structure of monomeric MDA5 lacking
2CARD in complex with dsRNA, which allowed direct compar-
ison with RIG-I:dsRNA complex structures. Second, we assem-
bled a model of the MDA5 filament with the crystal structure as
a building block and distance constraints derived from protein:
protein crosslinking experiments. Finally, we incorporated
2CARD into the filament model by extrapolation of the require-
ment for an oligomeric assembly of 2CARD in signaling.
RESULTS
MDA5 Binds to 12 bp dsRNA with 1:1 Stoichiometry
Weattempted crystallization of humanMDA5 lacking the 2CARD
domain (MDA5DN, residues 298–1025) and a further truncation
variant, MDA5DN’, that lacks both an internal loop (residues
645–662) and the C-terminal tail (residues 1018–1025). Crystals
were obtained only fromMDA5DN’ in complex with 12 bp dsRNA
(50-AGGGCCGCGGAT-30) and an ATP analog, 50-adenyl-b-
imidodiphosphate (ADPNP). The loop645–662 and the C-terminal
tail are not well conserved (Figure S1A available online), and
deletion of these residues did not affect RNA-binding affinity or
the ATP-hydrolysis activity of MDA5 (Figures S1B–S1D).
The crystals belonged to space group P212121 and diffracted
to 3.56 A˚ resolution. The structure was determined by molecular
replacement and refined to Rwork = 27.6% and Rfree = 32.0%
(Table S1). Simulated annealing omit maps (Figures S1F, S2A,
and S3B) validated domain organization and other features
described in this paper. The asymmetric unit contains two
ternary complexes of MDA5DN’:dsRNA:ADPNP with a stoichi-
ometry of 1:1:1. The stoichiometry of MDA5:12 bp dsRNA was
further confirmed in solution using Multiangle light scattering
(Figure S1E).
MDA5 Forms a Ring around dsRNA: Commonality with
RIG-I
The structure of the ternary complex revealed that MDA5DN’
forms a ring structure around the 12 bp dsRNA, an architecture
that resembles RIG-IDN bound to dsRNA. Several key features
that distinguish MDA5 from RIG-I were also observed, but we
will first describe the domain organization and ATP-binding
mode that are globally shared between MDA5 and RIG-I.
MDA5DN’ consists of the two RecA-like domains (Hel1 and
Hel2), the intervening Hel2i domain, the pincer domain, and the
CTD (Figure 1A). In the structure of MDA5DN’:dsRNA, these
domains are arranged in the order of Hel1-Hel2-Hel2i-CTD
around dsRNA counterclockwise from the top view, whereas
the V-shaped pincer domain wraps around dsRNA clockwise
(Figure 1B). In this arrangement, MDA5 interacts with dsRNAusing Hel1, Hel2i, Hel2, and CTD, but not the pincer domain
(Figure 1C). Most protein residues interact primarily with the
RNA phosphate backbone and 20 hydroxyl groups, consistent
with the sequence-independent recognition of dsRNA (Peisley
et al., 2011). These interactions are conserved in RIG-I with the
exception of the residues in the CTD (to be discussed later).
To examine the importance of individual domains in dsRNA
recognition, residues from each of Hel1, Hel2i, Hel2, and
CTD were individually mutated into alanine, and the IFN-b
reporter assay was used to examine the signaling activities
of these mutants in 293T cells. Stimulation of cells with
polyinosinic:polycytidylic acid (pIC), a dsRNA analog known to
activate MDA5, induced robust IFN-b promoter activity upon
ectopic expression of wild-type (WT) MDA5 but not in the empty
vector control (Figure 1D), suggesting that the observed IFN-b
signaling is mediated by MDA5. Comparison of WT MDA5 and
the point mutants identified several residues, at least one residue
per domain, that significantly affect the signaling activity of
MDA5 in response to pIC (Figure 1D), indicating that all domains
are important for efficient dsRNA recognition.
Cocrystallized ADPNP is bound at the cleft between Hel1 and
Hel2 in the outer rim of the MDA5 ring structure (Figures 1B
and S1F). Superposition of MDA5 with RIG-I bound to dsRNA
and ADP,BeCl3, another ATP analog, by aligning the protein
backbone showed a good agreement in their ATP-binding
modes. Although detailed analysis of the ADPNP:MDA5 interac-
tion is difficult at the current resolution, the triphosphate group of
ADPNP, which is buried deep inside the cleft near residues
332–335, could be unambiguously identified (Figure 1E). The
face of the adenine base is placed between the side chains of
R309 and R337 (Figure S1F), whereas the edges of the base
are within contact distance of Q312 and Q307, which, together,
could contribute to the specificity of MDA5 for ATP.
MDA5CTDBinds to the dsRNAStem,whereasRIG-I CTD
Caps the dsRNA End
A major difference between MDA5 and RIG-I was observed
in the orientation of the CTD. In the MDA5DN’:dsRNA struc-
ture, the long axis of the CTD is approximately parallel to the
axis of dsRNA, which leaves an 30 gap between Hel1 and
the CTD when viewed from the bottom of the ring (Figures 2A
and 2B). This C-shaped ring of MDA5 differs from the RIG-I
structure, where the CTD is tilted by 20 toward the dsRNA,
which brings the bottom tip of the CTD closer to Hel1 and forms
an asymmetrically closed O-ring around dsRNA (Figures 2A
and 2B).
Closer inspection of the CTD:dsRNA interactions in MDA5 and
RIG-I revealed that the differential orientation of the CTD is
accompanied by dsRNA stem binding by MDA5 versus dsRNA
end binding by RIG-I. The RIG-I CTD rigidly caps the end of
dsRNA using a loop of residues 848–860, which plays an impor-
tant role in the recognition of 50ppp and blunt end of dsRNA. By
contrast, the equivalent loop (residues 945–958) in MDA5 is
disordered, and dsRNA stem recognition is mediated by resi-
dues on the flat surface of the CTD (Figure 2C). In the previous
structures of the isolated MDA5 CTD without RNA (Li et al.,
2009; Takahasi et al., 2009), this loop (CTD loop) adopts a
conformation similar to that of RIG-I with or without RNACell 152, 276–289, January 17, 2013 ª2013 Elsevier Inc. 277
Figure 1. Overview of the Structure of MDA5DN’:12 bp dsRNA:ADPNP
(A) Schematic of domain organization of human MDA5 with domain boundaries marked by residue numbers.
(B) Top and side views of the ternary complex of MDA5DN’:12 bp dsRNA:ADPNP in cartoon and surface representation, respectively. Cocrystallized ADPNP is
shown as a sphere model (top view). Individual domains are colored as in (A).
(C) Schematic diagram of the MDA5DN’:dsRNA interactions. Protein residues are colored as in (A).
(D) IFN-b reporter assays of MDA5 and its point mutants (mean ± standard deviation [SD], n = 3). Dual luciferase activities were measured in 293T cells with
and without stimulation with pIC.
(E) Schematic diagram of MDA5DN’:ADPNP interaction.
See also Figure S1 and Table S1.(Figure S2B). Superposition of the isolated MDA5 CTD onto the
MDA5DN’:dsRNA structure revealed that dsRNA would occupy
the same space as the CTD loop in the RNA-free conformation
(Figure S2C), suggesting that displacement of the CTD loop is
required for dsRNA binding. Consistent with this interpretation,
shortening of the loop by deleting residues 945–955 (DCTDloop)
did not affect the RNA-binding affinity (Figure 2D) and slightly
increased the RNA-dependent ATP-hydrolysis activity (Fig-
ure S2D). Interestingly, the CTD loop is conserved among
MDA5 homologs (Figure S2E), and the signaling activity of the
DCTDloop mutant is lower, albeit slightly, than that of WT
MDA5 (Figure S2F), suggesting that the CTD loop may play as
yet unidentified roles in MDA5 function.278 Cell 152, 276–289, January 17, 2013 ª2013 Elsevier Inc.Hel2i Provides a Docking Site for MDA5 CTD to Be
Positioned near the dsRNA Stem
Although the orientation of the dsRNA-bound MDA5 CTD is
distinct from that of the RIG-I CTD, the conformation of the heli-
case domain is preserved (Ca root-mean-square deviation
[rmsd] of 1.9 A˚), which prompted the question of what role the
helicase domain plays in the divergent evolution of dsRNA spec-
ificities. The structures of MDA5 and RIG-I bound to dsRNA
show that the CTDs of both proteins form an extensive, long-
range intramolecular interaction with Hel2i with buried surface
areas of 521 A˚2 and 504 A˚2, respectively (Figure 3A). The convex
surface of the zinc-binding site in the CTD is complementary to
the concave surface of Hel2i (Figure 3B), and both the CTD
Figure 2. MDA5 Forms an Open Ring Structure around the dsRNA Stem by Orienting the CTD Parallel to the dsRNA Axis
(A and B) Side (A) and bottom (B) views of MDA5DN’ (left) and RIG-IDN (right, PDB: 3TMI) bound to dsRNA. The long axis of the CTD (magenta) is indicated by an
arrow (side view). On the right, the MDA5 CTD is superposed onto the RIG-I CTD by aligning the helicase domain. RIG-I is colored yellow in the superposed
structure.
(C) Comparison of the MDA5 and RIG-I CTDs. The CTD loop in RIG-I (residues 846–859, green, PDB: 3TMI) rigidly caps the dsRNA end, whereas the equivalent
loop in MDA5 (residue 945–955) is disordered in the structure of the MDA5DN’:dsRNA complex.
(D) EMSA of 112 bp dsRNA with WT and the DCTDloop mutant of MDA5DN (mean ± SD, n = 3).
See also Figure S2.and Hel2i undergo little conformational change upon complex
formation (Figure S3A). We asked whether this rigid-body dock-
ing of the CTD against Hel2i plays a role in the differential orien-
tation of the CTD in MDA5 and RIG-I. Superposition of the
complex structures of MDA5 and RIG-I by aligning the Hel2i
domains showed that the RIG-I CTD is 10 A˚ farther removed
from Hel2i than the MDA5 CTD (Figure 3C). Notably, helix a12
in RIG-I Hel2i at the interface with the CTD is 10 residues longer
than in MDA5 in all species examined (Figure 3D), and the resul-
tant protrusion of helix a12 could push the RIG-I CTD away from
Hel2i. Consistent with the importance of the surface comple-
mentarity between Hel2i and the CTD, a chimera that contains
RIG-I helicase and MDA5 CTD has a significantly lower affinity
for dsRNA than full-length MDA5 (Figure 3E). Thus, despite
having a similar conformation, the helicase domain of MDA5 is
not interchangeable with that of RIG-I, and its role is beyond
simply providing additional RNA affinity but likely includesprecise positioning of the CTD for efficient recognition of the
dsRNA stem.
Hel2 Recognizes the dsRNA Stem by Inserting a Loop
into the Major Groove
By comparison to RIG-I, the dsRNA stem-binding mode of
MDA5 results in a differential positioning of the dsRNA relative
to the helicase domain, in particular the loop in the Hel2 domain
(residues 758–767, Hel2 loop). In the MDA5DN’:dsRNA struc-
ture, the Hel2 loop is inserted into themajor groove of the dsRNA
stem, whereas in RIG-I, it binds to the dsRNA end (Figures 4A
and S3B). The major groove, which often serves as a se-
quence-dependent recognition site for dsDNA-binding proteins,
is typically too narrow in dsRNA to accommodate a protein
secondary structure. In the MDA5:dsRNA complex, the major
groove is widened from 12 A˚ to 18 A˚ at the site of Hel2 loop
insertion (Figure 4A), but unlike many DNA-binding proteins,Cell 152, 276–289, January 17, 2013 ª2013 Elsevier Inc. 279
Figure 3. CTD Is Rigidly Held by Hel2i through Surface Complementarity
(A) Top view of the MDA5DN’:dsRNA complex showing the long-range interaction between Hel2i (orange) and the CTD (purple). Hel1, Hel2 (gray), and Hel2i form
one continuous half-ring structure that is connected to the CTD (purple) via the long, partially disordered pincer domain (blue).
(B) Surface representation of Hel2i and the CTD within the MDA5DN’:dsRNA complex. See also Figure S3A.
(C) Superposition of the structures of Hel2i:CTD of MDA5 (orange:magenta) and RIG-I (yellow:yellow, PDB: 3TMI) by aligning the Hel2i backbone.
(D) Sequence alignment of MDA5 and RIG-I homologs near helix a12 in Hel2i.
(E) EMSA of 112 bp dsRNA with WT MDA5 and a chimera consisting of RIG-I 2CARD-helicase and MDA5 CTD.the interaction between the inserted loop and dsRNA is limited to
the phosphate backbone and does not lead to a sequence-
dependent base recognition.
To examine the importance of the Hel2 loop in dsRNA
recognition, we engineered MDA5DN lacking the Hel2 loop
(DHel2loop) and tested its ability to bind dsRNA and hydrolyze
ATP. Interestingly, DHel2loop did not affect dsRNA affinity (Fig-
ure 4B) but completely abolished the dsRNA-dependent ATP-
hydrolysis activity (Figure 4C), which was unexpected based
on DHel2loop’s distant location from the ATP-binding site (Fig-
ure 4D). In the cell, DHel2loop led to a complete loss of signaling
activity (Figure 4E), consistent with the previous proposal that
ATP hydrolysis is important for signal activation (Yoneyama
et al., 2005). These observations suggest that insertion of the
Hel2 loop into the major groove is important not for RNA binding
but for ATP hydrolysis and subsequent signaling and could
potentially serve as an additional mechanism to discriminate
between dsRNA and other types of nucleic acids.
Monomers in MDA5 Filaments along dsRNA Are
Arranged Head-to-Tail
We next asked how the MDA5 ring stacks along dsRNA to form
the filamentous oligomers that we observed in our previous EM
studies (Peisley et al., 2011). The packing of the individual280 Cell 152, 276–289, January 17, 2013 ª2013 Elsevier Inc.MDA5 molecules in our crystal does not recapitulate the contin-
uous filament architecture, possibly reflecting incompatibility
between the filament geometry and the crystal packing. The
crystal structure enabled us, however, to build filament models
by joining MDA5 monomers either in a head-to-tail or head-
to-head/tail-to-tail arrangement (Figure 5A). We used two
constraints in building the models, namely preserving the helical
symmetry of dsRNA at the monomer:monomer interface and
avoiding a severe clash and gap between the adjacent mono-
mers. The resultant head-to-tail model shows a repeating unit
of 14 bp and a turn of 70 per monomer, which places helix
a10 (in the head surface of monomer 1) right below a18 (in the
tail surface of monomer 2) (Figure 5A). In the head-to-head and
tail-to-tail models, the two adjacent monomers are related by
a two-fold symmetry, and helix a18 of monomer 1 is placed
next to another a18 of monomer 2 but away from a10 (Figure 5A).
To distinguish between the head-to-tail and head-to-head/
tail-to-tail models, we employed a Cys-based protein-protein
crosslinking (X-linking) strategy to take advantage of the fact
that MDA5DN’ contains only four surface-exposed Cys’s. To
identify residues proximal to a10, we first mutated the four native
Cys’s to Ala’s and engineered a new Cys at position 556, 559, or
563 within the helix a10 and at position 860 within the head
surface but outside the putative interface as a negative control.
Figure 4. The Hel2 Loop Is Inserted into the Major Groove of dsRNA
(A) Position of the Hel2 loop (red) relative to dsRNA in MDA5 (left) and RIG-I (right, 3TMI). The Hel2 loop of MDA5 is inserted into the major groove, which is
accompanied by widening of the major groove from 12 A˚ to 18 A˚, whereas the RIG-I loop is near the dsRNA endwith little change in the width of the major groove.
See also Figure S3B.
(B) EMSA of 112 bp dsRNA with WT MDA5DN and the DHel2loop mutant (mean ± SD, n = 3).
(C) Time course of ATP hydrolysis by WT MDA5DN and the DHel2loop mutant (mean ± SD, n = 3).
(D) Top view of MDA5 Hel2 with dsRNA and ADPNP.
(E) IFN-b reporter assays of WT and DHel2loop of full-length MDA5 (mean ± SD, n = 3).These four sites are equally solvent accessible in the structure of
the MDA5DN’ monomer, and their Cys mutants bind to dsRNA
and form filaments as efficiently as WT MDA5 (Figures S4A–
S4C). We first examined whether these Cys mutants can be
X-linked with bis-maleimidoethane (BMOE), which is known to
introduce Cys-Cys, and to some extent, Cys-Lys X-links at
pH 7.5, the reaction condition used in our assays. We compared
the X-linking efficiency of the mutants when bound to 112 bp or
15 bp dsRNA, which accommodates eight or single MDA5
monomers, respectively. Incubation of the C559 mutant with
112 bp dsRNA, but not with 15 bp or without RNA, led to exten-
sive intermolecular X-linking that displayed a ladder pattern in
SDS-PAGE (Figure 5B). This differs from intramolecular X-links
(migrating near the uncrosslinked protein), which were present
in all samples independent of RNA. The 112 bp-mediated inter-
molecular X-linking was also highly dependent on the position of
the Cys; C563 displayed a less extensive ladder pattern than
C559, whereas C556 and C860 showed little or no ladder forma-
tion (Figure 5B). To examine the possibility of 112 bp dsRNA
inducing nonspecific bridging of MDA5 monomers as opposed
to cooperative filament formation, we compared the X-linking
efficiency in the presence of 2- to 5-fold excess of 112 bp dsRNA
over protein to selectively suppress a nonspecific bridging
effect. No difference was observed in either the X-linking
pattern or efficiency (Figure S4D), suggesting that intermolecular
X-linking is due to specific filament formation.
To identify the X-linking partner of C559, we performed liquid
chromatography-mass spectrometry (LC-MS) and liquid chro-matography-tandem mass spectrometry (LC-MS/MS) analyses
on the in-gel tryptic digests of the 112 bp-specific X-linked prod-
ucts.We compared inter- and intramolecular X-links to unambig-
uously identify intermolecularly X-linked peptides. The most
prominent peptide from intermolecular but not intramolecular
X-link digest was detected at mass-to-charge ratio (m/z)
671.023+ (Figure 5C). This peptide was subject to cleavage in
MS/MS analysis, which indicated K777 as the X-link partner of
C559 (Figure 5D). To confirm this result, we also used sulfo-
MBS, a more commonly used Cys-Lys X-linker, and identified
the same C559-K777 pair as the most prominent X-link that is
present only in the intermolecularly but not in the intramolecularly
X-linked species (Figures S4E–S4G).
These results show that, in the filament, K777 from helix a18 is
in close proximity to C559 from helix a10, which is compatible
with the head-to-tail but not the head-to-head or tail-to-tail
model. Furthermore, the high sensitivity of X-linking to the Cys
position imposes strong geometry constraints that specifically
support the filament model with an interval of 14 bp but not
13 bp or 15 bp. In the model with a 14 bp interval, the Cb atom
of K777 is at a distance of 17, 12, or 15 A˚ from the Cb atoms
of C556, C559, or C563, respectively (Figure 5E). Considering
the length of Lys and Cys side chains (4–5 A˚ between Cb and
Nz in Lys and 1.8 A˚ between Cb and Sg in Cys) and the arm
length of BMOE (8 A˚), C559 and potentially C563, but not
C556, can be within the X-link distance limit. In the head-to-tail
models with 13 bp and 15 bp intervals, the distance between
Cb’s of K777 and C559 (>16 A˚) are beyond the BMOE X-linkingCell 152, 276–289, January 17, 2013 ª2013 Elsevier Inc. 281
Figure 5. MDA5 Forms a Head-to-Tail Filament In Vitro and In Vivo
(A) Side and top views of head-to-tail and head-to-head/tail-to-tail models of the MDA5DN’ filament; models were built based on the structure of the
MDA5DN’:dsRNA complex. Bridging RNA (gray) was added to join monomers while preserving dsRNA continuity.
(legend continued on next page)
282 Cell 152, 276–289, January 17, 2013 ª2013 Elsevier Inc.
limit, and there are significant levels of steric clash and gap
between the adjacent monomers, respectively. This model
predicts pseudo-five-fold symmetry (70 turn per monomer)
within a filament, which is in agreement with the recent EM anal-
ysis of the mouse MDA5 filament (Berke et al., 2012).
We used the head-to-tail model with an interval of 14 bp to
predict the monomer:monomer interface with the total buried
surface area of 1,500 A˚2, which largely involves interaction
between the helicase and helicase or pincer domains. To
examine this filament model in the cell, we designed three pairs
of mutations, I541R/E543R, M570R/E572R, and I841R/E842R,
on the head surface at the putative interface and one pair of
control mutations, E552K/E556K, on the head surface just
outside the interface (Figure 5F). These residues, which are
conserved in MDA5 but not in RIG-I (Figure S4H), are not in
contact distance from dsRNA in our structure. The three pairs
of mutations at the putative interface showed a range of negative
and additive impact on the signaling activity of MDA5 as
measured by IFN-b reporter assays, whereas the control muta-
tion did not (Figure 5G). Of note, the least active mutant,
I841R/E842R, displayed reduced affinity for 112 bp dsRNA
while retaining the WT affinity for 15 bp dsRNA. As affinity
for long dsRNA reflects both protein monomer:RNA and
monomer:monomer interactions within the filament, whereas
affinity for 15 bp dsRNA reflects the intrinsic monomer:RNA
interaction, these results suggest that the mutation specifically
disrupts the monomer:monomer interaction within the filament
(Figure 5H). Consistent with this notion, EM analysis showed
that I841R/E842R forms short fragments of filaments dispersed
along 1012 bp RNA (Figure 5I). Altogether, these observations
support formation of the head-to-tail MDA5 filament in the cell
and its importance for signaling.
Isolated MDA5 2CARD Forms Elongated Oligomers
In pursuit of understanding the architecture of a filament formed
by full-length MDA5 and the mechanism for signal activation,
we asked how the signaling domain, 2CARD, which is absent
in our crystal structure or in the filament model, is arranged
within the MDA5 filament. In our previous EM analysis, class-
averaged projection images of the MDA5 filament only showed
a ring structure and lacked any density that could correspond
to 2CARD (Peisley et al., 2011). This observation suggests(B) Krypton stain of an SDS gel of BMOE-X-linkedMDA5DN’ variants containing C
or 112 bp dsRNA prior to X-linking with BMOE.
(C)Mass spectrometric analysis of inter- versus intramolecular X-link of the C559m
(B), and subjected to mass spectrometry, which identified a peptide ofm/z 671.0
(D) Tandemmass spectrum of the peptide (m/z 671.023+) from (C). C terminus cont
fragment ions from neutral loss.
(E) Magnified view of the a10 (head) -a18 (tail) interface from the head-to-tail mo
or C563.
(F) Location of residuesmutated in (G) (spheres). I541/E543, M570/E572, and I841
just outside the interface.
(G) IFN-b reporter assays of WT MDA5 and mutants (residues shown in F) upon
(H) EMSA of WT and I841/E842 mutant MDA5DN with 112 bp or 15 bp dsRNA.
(I) Representative EM images ofWT and I841R/E842RmutantMDA5DN (0.3 mM) b
the mutant complex are indicated by arrows.
See also Figure S4.that 2CARD does not constitute the core filament architecture
and is flexible. The linker between 2CARD and the helicase
domain is 100 amino acids long and is predicted to be
largely disordered (Figure S5A). Comparison between MDA5
and MDA5DN filaments showed little difference in filament
morphology (Figure 6A). To better locate 2CARD with respect
to the core filament, we fused a 60 kDa E. coli protein, NusA,
to the N terminus of MDA5. NusA-MDA5 assembled into
thicker filaments than MDA5DN (width of 12–18 nm in compar-
ison to 9 nm) and displayed a more rugged filament surface
with irregular bulges appearing along the filament (Figure 6A).
This observation suggests that NusA-2CARD decorates the
outer surface of the MDA5 core filament with a high degree of
heterogeneity.
Self-oligomerization is a common molecular property of many
members of the death domain superfamily (Ferrao and Wu,
2012), which 2CARD belongs to, and can often be reconstituted
by overexpression. We overexpressed isolated 2CARD in E. coli
and analyzed the purified protein by size-exclusion chromatog-
raphy (SEC). We found that 30%–40% of 2CARD existed in
high-molecular-weight species (HMW) and 40%–50% in low-
molecular-weight species (LMW) (Figure 6B). This is different
from RIG-I 2CARD, which expressed predominantly as a mono-
mer (Figure S5B). Purified HMWand LMWofMDA5 2CARDwere
stable with no apparent change in size over 6 hr, but HMW
gradually broke down into smaller pieces upon dilution, and
LMW converted to HMW upon concentration, suggesting their
concentration sensitivity. Under EM, the HMW species dis-
played heterogeneous, elongated oligomeric architectures that
were 20–60 nm long and 13 nm wide (Figure 6C). The struc-
ture of MDA5 2CARD is unknown, but based on the size of RIG-I
2CARD (5 nm long and 2.5 nm wide) in the crystal structure of
full-length RIG-I (Kowalinski et al., 2011), we suspect that the
HMW of MDA5 2CARD consists of multiple 2CARD molecules
in both width and length. Despite the heterogeneity, such an
elongated shape is distinct from dysfunctional protein aggre-
gates that usually display a round or amorphous shape, as was
seen with loss-of-function mutant G74A/W75A 2CARD (Fig-
ure 6C) (Jiang et al., 2012). This result suggests that the observed
elongated shape of WT 2CARD HMW reflects an intrinsic
propensity of 2CARD to self-assemble into a defined oligomeric
arrangement.ys at positions 556, 559, 563, or 860. The proteins were preincubatedwith 15 bp
utant. The BMOE-X-linked bands were in-gel digested, excised as indicated in
23+ that was only present in the inter- but not intramolecularly X-linked sample.
aining fragment ions y and y’ indicates that C559 is X-linked to K777. * indicates
del in (A). Distances were measured between Cb’s of K777 and C556, C559,
/E842 are on the head surface at the putative interface, whereas E552/E556 are
pIC stimulation (mean ± SD, n = 5).
ound to 1012 bp dsRNA (2.4 mg/ml). Long stretches of naked dsRNA exposed in
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Figure 6. MDA5 2CARD Forms Functional Oligomers
(A) Electron micrographs of filaments formed by MDA5DN, MDA5, and NusA-MDA5 with 1,012 bp dsRNA.
(B) Overlaid SECs (Superdex200 10/300) of purified isolated 2CARD of WT MDA5 and the G74A/W75A mutant.
(C) Electron micrographs of HMW species of 2CARD of WT MDA5 and the G74A/W75A mutant.
(D) Schematic of domain organization and purification procedure of MAVS CARD-S with and without refolding.
(legend continued on next page)
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MDA5 2CARD Oligomers, but Not Monomers, Promote
MAVS Filament Formation
To examine the significance of the oligomerization of MDA5
2CARD, we developed biochemical assays to monitor the effect
of HMW of MDA5 2CARD on the activation of the signaling
adaptor MAVS. Previous studies showed that MDA5 and RIG-I
2CARD activate MAVS by promoting formation of prion-like fila-
ments consisting of the N-terminal CARD of MAVS (Hou et al.,
2011). To examine the impact of MDA5 2CARD on formation of
MAVS CARD filaments, we expressed and purified recombinant
MAVS CARD fused to a SNAP tag (18 kDa) (Figure 6D), which
increased solubility of the protein and allowed fluorescent
labeling for monitoring formation of MAVS filaments. MAVS
CARD fused to SNAP (CARD-S), but not SNAP alone, expressed
as short (30–100 nm) fragments of filaments (Figure 6E), which
resemble the filament of MAVS CARD purified from mammalian
cells (Hou et al., 2011). To examine the prion-like property for the
CARD-S filament, we performed a seeding experiment bymixing
CARD-S filament seeds with monomeric CARD-S. We prepared
monomeric CARD-S by chemical denaturation of CARD-S fila-
ments followed by refolding and SEC in native buffer (Figure 6D).
This procedure produced amonomeric CARD-S that is stable for
at least 24 hr before it spontaneously forms filaments over the
course of 3–7 days. To distinguish between the seed filaments
and monomeric CARD-S, we labeled monomeric CARD-S with
Alexa 488 (CARD-S*, * indicates fluorescent labeling). When
monomeric CARD-S* was mixed with unlabeled seed filaments,
CARD-S*was rapidly incorporated into the filament within 30min
as evidenced by EM and the mobility shift in the native gel
(Figures 6F, 6G, and S5E). In addition, the lengths of the resultant
filaments were inversely related to the added amount of seed
filaments (Figures 6F and 6G), a growth characteristic similar to
prions.
We next examined whether monomeric CARD-S* can form
filaments de novo (in the absence of seed filaments) in
response to RIG-I and MDA5 2CARD. Previous studies
showed that RIG-I 2CARD can promote formation of MAVS
filaments on mitochondria upon addition of free chain of K63-
linked tetraubiquitin (K63-Ub4) (Hou et al., 2011). Using puri-
fied, monomeric CARD-S*, we also observed that the com-
bination of RIG-I 2CARD and K63-Ub4 but not K48-Ub4 or
linear Ub4 induced a mobility shift of CARD-S* in a native gel
(Figures 6H and S5F) and formed filaments as seen by EM
(Figure 6I). Both LMW and HMW of RIG-I 2CARD stimulated
CARD-S* filament formation with LMW being more effective
(Figure 6H). These results suggest that RIG-I-mediated MAVS(E) EMs of CARD-S with and without refolding.
(F) CARD-S filament extension assay. Unlabeled seed filaments of CARD-S were
Alexa 488 label, 10 mM) at the indicated mass ratios for 30 min at RT prior to gel a
CARD-S* transitioning from the monomeric to the filamentous state.
(G) EMs of the extended filaments of CARD-S from (F).
(H) CARD-S filament formation assay. Alexa 488-labeled, monomeric CARD-S* (
and without K63-Ub4 (2.5 mM) for 2 hr at RT prior to gel analysis. Shown is an Al
(I) EMs of a CARD-S filament induced by MDA5 2CARD (HMW) alone or RIG-I 2C
(J) Comparison of CARD-S filament formation in the presence and absence of
performed as in (H).
See also Figure S5.activation can be reconstituted with purified, soluble MAVS
CARD.
Next, we incubated CARD-S* with MDA5 2CARD. Unlike
RIG-I, we did not observe any stimulatory effect of K63-Ub4 on
MDA5 2CARD in inducing CARD-S* filament formation (Fig-
ure 6H). However, HMW, but not LMW, of MDA5 2CARD was
able to induce a mobility shift of CARD-S* in EMSA and filament
formation by EM (Figures 6H–6J). HMW of the loss-of-function
mutant G74A/W75A did not stimulate CARD-S* filament forma-
tion (Figures 6H–6J). In addition, filament formed by MDA5
2CARD HMW displayed prion-like properties as it rapidly incor-
porated monomeric CARD-S labeled with Alexa 647 into the fila-
ment (Figure S5G). These results suggest the importance of
2CARD oligomerization for MAVS activation.
2CARD Oligomerization in the Full-Length MDA5
Filament
The requirement of 2CARD oligomerization for signaling sug-
gests that 2CARD must oligomerize within the MDA5 filament
to activate MAVS. The structure of full-length RIG-I revealed
that 2CARD is masked by an intramolecular interaction in the
absence of dsRNA but becomes exposed upon dsRNA binding
(Kowalinski et al., 2011). Assuming a similar scenario for MDA5,
one might expect that release of 2CARD upon dsRNA binding
could be sufficient for 2CARD oligomerization. However, we
found that MDA5 bound to 15 bp dsRNA is monomeric (Fig-
ure S6A), suggesting that exposure of 2CARD is insufficient to
induce its oligomerization. This result is consistent with our
observation that isolated 2CARD does not spontaneously oligo-
merize until it is highly concentrated.
We next asked what factors besides dsRNA binding would
be required for oligomerization of 2CARD in full-length MDA5.
Filament formation could bring multiple 2CARDs into proximity
and could promote oligomerization. However, our and others’
observations that catalytic mutants are impaired in signaling
(Figures 4E and S6B) (Yoneyama et al., 2005) prompted us to
examine how ATP hydrolysis regulates signaling, in particular
the conformation of 2CARD. We employed a protease-protec-
tion assay with N-terminally labeledMDA5 tomonitor proteolysis
of 2CARD. As ATP hydrolysis induces repetitive cycles of fila-
ment assembly and disassembly (Berke and Modis, 2012; Peis-
ley et al., 2011), which would complicate the analysis, we used
several nonhydrolyzable analogs mimicking ATP at various
stages of hydrolysis to probe conformational rearrangement
during ATP hydrolysis. We found protection of 2CARD against
chymotrypsin, trypsin, and proteinase K in the presence ofincubated with Alexa 488-labeled, monomeric CARD-S (CARD-S*, * indicates
nalysis. Shown is an Alexa 488 fluorescence gel image to specifically monitor
10 mM) was incubated with HMW or LMW of MDA5/RIG-I 2CARD (10 mM) with
exa 488 fluorescence gel image.
ARD (LMW) and K63-Ub4. Experiments were performed as in (H).
HMW 2CARD of WT MDA5 and the G74A/W75A mutant. Experiments were
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Figure 7. Oligomerization of 2CARD in the Full-Length MDA5 Filament
(A) Protease-protection assay. MDA5 with the N-terminal fluorescein label (star) was incubated with or without 15 bp or 1,012 bp dsRNA, and ADPNP, ADP,AlFx,
or ADP, and subjected to limited-proteolysis by chymotrypsin, trypsin, or proteinase K prior to analysis by SDS-PAGE. See Extended Experimental Procedures
for details.
(B) Models of the full-length MDA5 filament. In the first two models, 2CARD forms a continuous filament along the helical trajectory of the MDA5 core filament or
alongside the core filament. Alternatively, 2CARD forms discrete patches of oligomers along the filament with heterogeneous size distributions. Inset: geometry
constrains used in the model. The size of 2CARD was predicted based on the structure of RIG-I 2CARD (Kowalinski et al., 2011). The maximum linker length,
25 nm, was calculated based on the secondary structure prediction (Figure S5A) and the assumption that each residue contributes an increment of 1.5 A˚ and3 A˚
within an a helix and a random coil, respectively.
See also Figure S6.ADP,AlFx (transition state or post-hydrolysis mimic) in compar-
ison to ADPNP (ground-state mimic), ADP (product after phos-
phate release), or without ligand (Figure 7A). This protection
was more effective when MDA5 was bound to long (1,012 bp)
dsRNA than with or without 15 bp dsRNA (Figure 7A). No such
dependence on the ATP analog was observed with the catalytic286 Cell 152, 276–289, January 17, 2013 ª2013 Elsevier Inc.mutant K335A (Figure S6C). These results support the notion
that ATP hydrolysis regulates the conformation of 2CARD, and
more protection of 2CARD in long dsRNA is consistent with its
oligomerization within the filament.
We next modeled 2CARD into the head-to-tail filament archi-
tecture of MDA5. We examined three models based on the
geometry constraints derived from the helical symmetry of the
MDA5 filament (Figure 5A), the size of 2CARD (based on RIG-I
2CARD structure), and the predicted length of the linker between
2CARD and the helicase domain (<25 nm). In the first twomodels
(Figures 7B, panels I and II), we examined whether it is possible
for 2CARD to form a continuous filament along or alongside the
MDA5 core filament. Calculation of the helical trajectory
suggests, however, that 2CARD cannot form a continuous fila-
ment along the helical trajectory because it is 30% longer
than the maximum length that 2CARD can cover (Figure 7B,
panel I). Alternatively, a 2CARD filament could run alongside
the core MDA5 filament as the linker is long enough to wrap
half around the core filament (Figure 7B, panel II). In this model,
2CARDwould need to be stacked linearly as the rise of theMDA5
core filament (4.5 nm) is only slightly shorter than 2CARD. This
linear arrangement, however, is incompatible with the intrinsic
preference of the isolated 2CARD (or other death domains;
Ferrao and Wu, 2012) to oligomerize in both width and length
(Figure 6C). Thus, we propose a model in which 2CARD forms
discrete patches of oligomers along the filament (Figure 7B,
panel III), where each patch resembles the local structure of
the 2CARD oligomer observed with isolated 2CARD (Figure 6C).
In this model, size, frequency, and positioning of individual
patches are stochastically determined during MDA5 filament
assembly and ATP hydrolysis with an upper size limit of 11
monomers per patch (number of monomers within the maximum
length of two linkers, 50 nm). The stochastic nature of 2CARD
clusters rationalizes heterogeneity of NusA-2CARD bulges
observed with the NusA-MDA5 filament (Figure 6A).
DISCUSSION
The vertebrate innate immune system utilizes pattern recogni-
tion receptors to detect a variety of molecular signatures from
a broad range of pathogens. Underlying this functional diversity
is a surprisingly small number of structurally distinct domains
that include the DExH box helicase domain in RIG-I and MDA5
and leucine-rich repeats in Toll-like receptors and Nod-like
receptors (Palsson-McDermott and O’Neill, 2007). How these
receptors utilize similar domain architectures to recognize vastly
different ligands and acquire a unique biological function is a
key recurring question. In order to understand the structural
mechanism for the divergent viral RNA recognition by RIG-I
and MDA5, we here provided unprecedented details of the
molecular architecture of MDA5, which has thus far lagged
behind our understanding of RIG-I. We used three approaches:
first, we determined the crystal structure of the MDA5DN’ mono-
mer bound to dsRNA; second, we modeled the MDA5 core
filament based on the crystal structure and geometry con-
straints fromprotein X-linking experiments; and finally, we added
2CARD into the model of the MDA5 core filament based on our
observation that 2CARD must oligomerize in order to activate
MAVS.
The crystal structure of MDA5DN’:dsRNA demonstrates that
MDA5 binds to dsRNA as amonomer with a global domain orga-
nization similar to that of RIG-I. However, MDA5 utilizes differen-
tial orientation of the CTD, which is 20 rotated compared with
the RIG-I CTD, to recognize the internal duplex structure ofdsRNA. This slight difference in CTD orientation results in an
open, C-ring-shaped structure of MDA5 that binds to the dsRNA
stem, as opposed to the O-ring structure that is formed by RIG-I
and caps the dsRNA end (Figures 2A and 2B). In addition, differ-
ential flexibility of a loop in the CTD (residues 945–955) also
appears to contribute to the divergent RNA selectivity of MDA5
and RIG-I. In RIG-I, this loop rigidly caps the end of dsRNA,
whereas in MDA5, it is displaced from the core CTD structure
as it competes with dsRNA for the same surface of the CTD
core (Figure S2C). The MDA5 helicase domain also contributes
to the dsRNA stem recognition despite sharing similar conforma-
tion with RIG-I. The Hel2i domain provides a docking site for the
CTD to be rigidly held near the dsRNA stem (Figure 3), and the
Hel2 loop inserts into the major groove, serving as a key check-
point in dsRNA-dependent ATP hydrolysis and signaling (Fig-
ure 4). Thus, close collaboration between the helicase domain
and the CTD provides the molecular basis for the divergent
RNA specificity of MDA5 and RIG-I.
Could this stem-binding mode occur with RIG-I? Although the
dsRNA end appears to be the primary site of recognition by
RIG-I, accumulating evidence suggests that RIG-I can also
recognize the dsRNA stem. Previous studies showed that
RIG-I-mediated signaling increases with dsRNA length at
a constant molar amount (i.e., constant amount of the dsRNA
end but increasing amount of stem), suggesting a positive role
of the dsRNA stem in activating RIG-I (Binder et al., 2011). In
addition, single-molecule analysis revealed that RIG-I translo-
cates during ATP hydrolysis, which inevitably requires at least
transient interaction between the dsRNA stem and RIG-I (Myong
et al., 2009). Binding of RIG-I to the dsRNA stem would require
a CTD conformation different from those in the crystal structures
of RIG-IDN:dsRNA. It is tempting to speculate that RIG-I
adopts a conformation similar to that of MDA5 for dsRNA stem
recognition.
The open ring structure of MDA5, but not the closed ring of
RIG-I, is compatible with the filament architecture we observed
in our previous EM studies (Peisley et al., 2011). The MDA5 fila-
ment is distinct from a ‘‘beads-on-a-string’’ type of oligomer as
evidenced by the proximity between the adjacent monomers
(within 8 A˚ X-linking distance), which is unaffected by the pres-
ence of an excess amount of RNA (Figure S4D). By identifying
the residues involved in X-linking, we demonstrated that
filaments are formed by stacking MDA5 monomers in a head-
to-tail arrangement with a 70 turn per monomer (Figure 5A).
This brings the helicase domain in contact with adjacent helicase
domains through an extensive protein:protein contact, which
rationalizes the observed high cooperativity of MDA5 in dsRNA
binding and its high affinity for long dsRNA far beyond the
linear combination of monomer interactions. Mutations at the
interface, but not at distal sites, impaired filament formation
of MDA5 in vitro and the signaling activity in the cell (Figures
5G–5I), further supporting the filament model and its importance
in vivo.
Defining the complete architecture of full-length MDA5
requires knowledge of the arrangement of 2CARD within the fila-
ment. With isolated 2CARD as a model system, we found that
2CARD can self-oligomerize into a higher-order structure at
high protein concentration, and that this oligomerization isCell 152, 276–289, January 17, 2013 ª2013 Elsevier Inc. 287
required for 2CARD to promote MAVS filament formation (Fig-
ure 6). Based on this requirement for 2CARD oligomerizaton,
and other geometric constraints derived from the MDA5 core
filament and the linker connecting between 2CARD and the
core filament, we reconstructed a model in which 2CARD forms
patches of signaling-competent oligomers along the MDA5 fila-
ment (Figure 7B, panel III). RNA binding was proposed to expose
otherwise autoinhibited 2CARD (Kowalinski et al., 2011), but our
MALS data (Figure S6A) and protease-protection assay (Fig-
ure 7A) suggest that, in addition to simple RNA binding, filament
formation and additional conformational rearrangement during
ATP hydrolysis are required for efficient oligomerization of
2CARD. Interestingly, our previous study showed that ATP
hydrolysis also promotes filament disassembly, but not every
ATP hydrolysis triggers MDA5 dissociation, especially on long
dsRNA due to stabilization by the filament architecture (Peisley
et al., 2011). We propose that the MDA5 filament provides a
platform not only to bring individual 2CARD into proximity but
also to allow formation and stable maintenance of 2CARD
oligomers by supporting ATP hydrolysis decoupled from
dissociation. The insufficiency of RNA binding and requirement
of ATP hydrolysis and 2CARD oligomerization for MAVS
activation are also shared with RIG-I, which appears to utilize
K63-linked polyubiquitin, instead of filament formation, for
2CARD oligomerization (Jiang et al., 2012). Future research is
needed to understand the precise nature of the dynamic
coupling of 2CARD oligomers to the MDA5 filament during ATP
hydrolysis and the mechanism that promotes MAVS filament
formation.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Extended Experimental
Procedures online.
Crystallization and Structure Determination
The MDA5DN’:dsRNA complex was assembled by mixing MDA5DN’
(1.5 mg/ml) and 12 bp RNA (Dharmacon) at a 2:1 molar ratio and was
concentrated to 10 mg/ml in buffer A (20 mM HEPES, pH 7.5, 150 mM
NaCl, and 2 mM DTT) with 2 mM ADPNP. Crystals were initially obtained as
small needles with the hanging-drop vapor-diffusion method from a 2:1
mixture of sample and reservoir buffer that contains 0.1 M MES (pH 6.5),
25% PEG300. Crystals were optimized with reservoir buffer containing
0.1MMES (pH 7.0), 30%PEG300, and 7%–11% sucrose and using themicro-
seeding method. Diffraction data were collected at NE-CAT beamline 24ID-C
at the Advanced Photon Source and processed using the program XDS
(Kabsch, 2010). The structure was determined by molecular replacement
with Phaser (McCoy et al., 2007) and refined with Phenix (Adams et al.,
2010) (see the Extended Experimental Procedures). A summary of data collec-
tion and structure refinement statistics is provided in Table S1.
Protein X-Linking and Mass Spectrometry
The four surface-exposedCys’s inMDA5DN’ (residues 496, 536, 860, and 951)
weremutated into Ala’s, and a newCyswas introduced at position 556, 559, or
563. The complex of MDA5DN’ and dsRNA was formed by mixing protein
(200 nM) and dsRNA (12 mM 15 bp or 50 nM 112 bp) in buffer A at 37C for
5 min. High concentration of 15 bp was used to compensate for the low affinity
of MDA5 for 15 bp in comparison to 112 bp (Peisley et al., 2011). Protein
X-linking was performed with 50 mM BMOE or sulfo-MBS (Pierce) at room
temperature (RT) for 10 min and quenched with 50 mM DTT for BMOE or
25 mM DTT and 0.25 M Tris for sulfo-MBS prior to gel analysis and mass
spectrometry (Extended Experimental Procedures).288 Cell 152, 276–289, January 17, 2013 ª2013 Elsevier Inc.MAVS CARD Filament Formation and Extension Assays
Refolded CARD-S was labeled with Alexa 488-benzylguanine (NEB)
according to the manufacturer’s instruction and further purified by SEC to
remove unincorporated dye. Filament formation assay was performed by
incubating monomeric, labeled CARD-S (CARD-S*) with 2CARD of RIG-I or
MDA5 in buffer A for 2 hr at RT prior to analysis by Bis-Tris native PAGE
(Life). Filament extension assay was performed by mixing unlabeled seed
filaments and monomeric CARD-S* in buffer A for 30 min at RT prior to
gel analysis. Fluorescent gel images were recorded using the scanner
FLA9000 (Fuji).
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